RVTY News - Candlesense

Revvity to Present at Upcoming Investor Conferences

WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY), today announced it will present at the following investor conferences: 2025 Wells Fargo Healthcare Conference Wednesday, September 3, 20...

Conference

4 days ago

Revvity Launches Innovative Reagent Technology to Accelerate Development of Next-Generation Targeted Therapeutics

WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY), today announced the launch of pHSense™ reagents, a powerful technology designed to advance internalization studies in drug discovery. pH...

Is there any accompanying sales guidance or forecasts from management that could move the stock price in the near term? How might this innovation influence Revvity's long‑term growth strategy and positioning within the biotech tools market? What regulatory or compliance hurdles, if any, could delay market rollout of the pHSense™ reagents?

Product launch

16 days ago